Omeprazol Zentiva (Omeprazole Sodium)

Omeprazole, the active ingredient in Omeprazol Zentiva, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It is employed in the treatment of gastro‑esophageal reflux disease, healing of gastric and duodenal ulcers, prevention of NSAID‑induced ulcer recurrence, and management of Zollinger‑Ellison syndrome in adult patients. GNH USA supplies Omeprazol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omeprazol Zentiva, a proton pump inhibitor, acts on conditions involving excess gastric acid secretion. - Gastro‑esophageal reflux disease (GERD): reduces acid exposure to the esophagus and alleviates heartburn symptoms. - Gastric and duodenal ulcers: promotes ulcer healing by suppressing gastric acid production. - NSAID‑induced ulcer recurrence: prevents re‑formation of ulcers in patients taking non‑steroidal anti‑inflammatory drugs. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with gastrin‑producing tumors.

Adverse reactions may occur with any medication and should be monitored by healthcare professionals.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: sensation of stomach upset. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased intestinal gas. - Dizziness: transient light‑headed feeling.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: abnormal liver function tests. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and urinary changes.

Before initiating therapy, consider patient‑specific factors and monitor for potential risks. - Renal impairment: adjust therapy and monitor renal function. - Hepatic disease: use with caution in patients with liver dysfunction. - Elderly patients: increased susceptibility to electrolyte disturbances. - Concomitant use of antiplatelet agents: monitor for bleeding risk. - Long‑term therapy: assess need for periodic evaluation of bone health and magnesium levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Omeprazol Zentiva may affect the pharmacokinetics of other medicines; interaction management is essential.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet activity. - Warfarin: potential alteration of anticoagulant effect. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum levels. - Diazepam: enhanced sedation. - Iron salts: decreased iron absorption. - Vitamin B12: potential reduction with prolonged use. - Calcium carbonate: reduced calcium uptake.